Search Orphan Drug Designations and Approvals
-
Generic Name: | O-(2-[18F]fluoroethyl)-L-tyrosine |
---|---|
Date Designated: | 04/20/2023 |
Orphan Designation: | Diagnostic for the management of malignant glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
UCSF Radiopharmaceutical Facility 185 Berry Street Suite 350 San Francisco, California 94107 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-